The Evolution of Risk Assessment in Pulmonary Arterial Hypertension

Sandhya Murthy, Raymond Benza

Research output: Contribution to journalArticlepeer-review


Pulmonary arterial hypertension (PAH) is a chronic debilitating disease that carries an unacceptably high morbidity and mortality rate despite improved survival with modern therapies. The combination of several modifiable and nonmodifiable variables yields a robust risk assessment across various available clinical calculators. The role of risk calculation is integral to managing PAH and aids in the timely referral to expert centers and potentially lung transplantation. Studies are ongoing to determine the role of risk calculators in the framework of clinical trials and to elucidate novel markers of high risk in PAH.

Original languageEnglish (US)
Pages (from-to)134-144
Number of pages11
JournalMethodist DeBakey cardiovascular journal
Issue number2
StatePublished - 2021


  • prognosis
  • pulmonary arterial hypertension
  • risk
  • survival

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'The Evolution of Risk Assessment in Pulmonary Arterial Hypertension'. Together they form a unique fingerprint.

Cite this